People

Albert Sokol

Partner

Albert (Al) L. Sokol has nearly 50 years of experience representing a variety of large, medium and small life sciences and technology companies, often in multinational transactions. Types of work include venture capital and private equity investments, mergers and acquisitions, spin-offs, general corporate counseling, strategic alliances, executive compensation, licenses, collaborations, intellectual property matters, litigation, and other types of assistance.

See More

Results
  • Merger between two UK and US flu vaccine companies, and then a venture capital financing, on behalf of venture capital (VC) and private equity (PE) funds in Sweden, France, United Kingdom and Switzerland
  • Merger between a large Japanese pharma and our client, a US biotechnology company, for several hundred million dollars. Our client developed therapeutics for central nervous system conditions, such as attention deficit hyperactivity disorder (ADHD), and during its eight years of development and growth, we assisted with a reverse merger, two score VC closings with investors from three countries, and all aspects of its operations and growth
  • Strategic alliance between our client, an EU company, and a US VC firm and a US biotech company, involving the EU company’s spin-off of IP into the biotech company, coupled with the VC financing of the biotech company
  • VC investment in a new US biotech company (total syndicate financing $270 million), for and following our EU client’s license to that company of the US intellectual property (IP) rights to a narcolepsy therapeutic
  • Spinoff from a major New England research university of IP for developing therapeutics that target antibiotic-resistant bacteria, followed by various VC investments, on behalf of several private and corporate VC funds from three countries

See More

Recognitions
  • The Legal 500 Untied States, 2019
  • Practical Law Company, Recommended for M&A and Corporate Transactions
  • Law & Politics, Super Lawyer
  • Boston Magazine, Securities & Venture Finance
Capabilities and industries
Regional markets
Community
  • Massachusetts Biotechnology Council, member
  • Chambers of Commerce of France, Australia, Germany, Sweden, UK, member
Credentials
Education
  • Boston University School of Law, JD
  • Yale University, BA
Admissions
  • Massachusetts
Languages
  • English